Literature DB >> 16723605

First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-beta-lactamase, IMP-18.

Nancy D Hanson, Ashfaque Hossain, Larry Buck, Ellen Smith Moland, Kenneth S Thomson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16723605      PMCID： PMC1479107          DOI： 10.1128/AAC.01440-05

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States.

Authors:  K Lolans; A M Queenan; K Bush; A Sahud; J P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

Review 2.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South Africa.

Authors:  J D Pitout; K S Thomson; N D Hanson; A F Ehrhardt; E S Moland; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

4.  Transferable imipenem resistance in Pseudomonas aeruginosa.

Authors:  M Watanabe; S Iyobe; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

5.  blaVIM-7, an evolutionarily distinct metallo-beta-lactamase gene in a Pseudomonas aeruginosa isolate from the United States.

Authors:  Mark A Toleman; Kenneth Rolston; Ronald N Jones; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191
  5 in total
  18 in total

1.  First occurrence of an IMP metallo-beta-lactamase in Aeromonas caviae: IMP-19 in an isolate from France.

Authors:  Catherine Neuwirth; Eliane Siebor; Frederic Robin; Richard Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

Review 2.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

3.  Molecular dynamic simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor.

Authors:  Freddie R Salsbury; Michael W Crowder; Stephen F Kingsmore; James J A Huntley
Journal:  J Mol Model       Date:  2008-11-28       Impact factor: 1.810

4.  Purification, crystallization and preliminary X-ray analysis of IMP-18, a class B carbapenemase from Pseudomonas aeruginosa.

Authors:  Takamitsu Furuyama; Yoshikazu Ishii; Norimasa Ohya; Kazuhiro Tateda; Nancy D Hanson; Akiko Shimizu-Ibuka
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-11-29

5.  Genetic context and biochemical characterization of the IMP-18 metallo-beta-lactamase identified in a Pseudomonas aeruginosa isolate from the United States.

Authors:  Luisa Borgianni; Silvia Prandi; Laurie Salden; Gisela Santella; Nancy D Hanson; Gian Maria Rossolini; Jean-Denis Docquier
Journal:  Antimicrob Agents Chemother       Date:  2010-11-01       Impact factor: 5.191

6.  IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico.

Authors:  Craig A Martin; Kazumi Morita; Julie A Ribes; Lalitagauri M Deshpande; Helio S Sader; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2008-03-24       Impact factor: 5.191

7.  Two novel class I integron arrays containing IMP-18 metallo-β-lactamase gene in Pseudomonas aeruginosa clinical isolates from Puerto Rico.

Authors:  T Martínez; G J Vazquez; E E Aquino; R V Goering; I E Robledo
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

8.  Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002.

Authors:  Ellen S Moland; Nancy D Hanson; Jennifer A Black; Ashfaque Hossain; Wonkeun Song; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

9.  Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases.

Authors:  Daniel J Wolter; Noha Khalaf; Iraida E Robledo; Guillermo J Vázquez; Maria I Santé; Edna E Aquino; Richard V Goering; Nancy D Hanson
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

10.  Extensively drug-resistant pseudomonas aeruginosa isolates containing blaVIM-2 and elements of Salmonella genomic island 2: a new genetic resistance determinant in Northeast Ohio.

Authors:  Federico Perez; Andrea M Hujer; Steven H Marshall; Amy J Ray; Philip N Rather; Nuntra Suwantarat; Donald Dumford; Patrick O'Shea; T Nicholas J Domitrovic; Robert A Salata; Kalyan D Chavda; Liang Chen; Barry N Kreiswirth; Alejandro J Vila; Susanne Haussler; Michael R Jacobs; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.